Duration
1 hr.

Summary

As sublobar resection becomes more prevalent for early stage lung cancer treatment, precise tumor localization has gained greater importance. Numerous bronchoscopic platforms are available for tumor localization, and a novel molecular imaging agent received FDA approval earlier this year. In this webinar, Workforce on New Technology Vice Chair, Natalie Lui, and two field-leading experts will provide an in-depth overview of the latest advancements in technology.

Moderators

Natalie Lui, MD
Stanford University
Stanford, CA

Graeme Rosenberg, MD
Keck School of Medicine of USC
Los Angeles, CA

Speakers

Janani S. Reisenauer, MD
Mayo Clinic
Rochester, MN

Sunil Singhal, MD
University of Pennsylvania School of Medicine 
Philadelphia, PA